Bromsite
Active Ingredient(s): BromfenacFDA Approved: * April 11, 2016
Pharm Company: * INSITE VISION INC
Category: Vision / Eye Health
Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID)[1] marketed in the US as an ophthalmic solution (brand names Prolensa and Bromday,[2] prior formulation brand name Xibrom, which has since been discontinued) by ISTA Pharmaceuticals for short-term, local use. Prolensa and Bromday are the once-daily formulation of bromfenac, while Xibrom was approved for twice-daily administration. In the European Union, the brand name is Yellox. Bromfenac is indicated f... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.